United States · FDA National Drug Code directory
FYARRO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80803-153_b04b03ee-fc3b-411d-a3ef-dfc537c3d6f0
- Product NDC
- 80803-153
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Sirolimus
- Labeler
- Aadi Bioscience, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211206
- Source listing expiry
- 20271231
Source-listed ingredients
- SIROLIMUS — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (80803-153-50) / 20 mL in 1 VIAL, SINGLE-USE · 80803-153-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →